KVP has acquired SafePath, according to an announcement reported by Pet Food Processing.

The transaction adds SafePath's product line to KVP's existing veterinary portfolio. At press time, the companies had not disclosed the purchase price, the expected closing date, or whether SafePath will operate as a standalone business unit or fold into KVP's existing operations.

KVP is a long-established supplier to the veterinary channel, distributing products across companion-animal practice retail and clinical supply. SafePath manufactures rapid diagnostic test kits used in veterinary settings, including point-of-care assays for infectious disease screening.

For veterinary practices, the immediate practical question is product availability. Acquisitions of diagnostic suppliers typically leave SKU numbers, ordering codes, and distributor relationships unchanged in the short term, but practices that stock SafePath assays should watch for notifications about changes to ordering channels, packaging, or technical support contacts as integration proceeds.

The deal also signals continued consolidation in the veterinary diagnostics and supplies sector, where larger distributors have been steadily acquiring point-of-care test manufacturers to broaden their one-stop-shop offerings to clinics. Practices weighing instrument and assay purchasing decisions may see expanded bundled pricing or consolidated ordering as KVP integrates the SafePath line.

No regulatory filing details, agency review, or timeline for integration were included in the initial announcement. Pet Food Processing, which reported the acquisition, listed no additional transaction terms.

KVP and SafePath have not publicly commented beyond the announcement, and further details on the acquisition's structure, financial terms, and operational changes are expected to surface in subsequent company statements.